Topic: Brain Function

« Back

Print this page

	Personalized Program The Personalized Program enables you to compile an individual program with events and contributions of your interest. Therefore, it can be used very well to plan your actual congress visit at an early point of time. Please log in to use the Personalized Program.	» Login » Identification » Help

	Sunday, 28. June 2009	next day »

No.	S-04 - Symposium
Time:	08.00-09.30
Room:	Room 252B
Topic:	Brain Function
Track:	1 Basic
Session title:	Social brain functions in schizophrenia and mood disorders
	Shigenobu Kanba, Japan	Chair
	Martin Brüne, Germany	Co-Chair

001	Charcterization of epathy deficits in psychiatric populations
	Simone Shamay-Tsoory, Israel	Speaker
002	Deficit in theory of mind predicts treatment outcome of depression
	Shigenobu Kanba, Japan	Speaker
003	Integrated approach of theory of mind and contextual processing deficits in schizophrenia: from neurocognitive deficits to clinical assessment
	Eric Brunet-Gouet, France	Speaker
004	Social cognition and deviant behavior in schizophrenia
	Martin Brüne, Germany	Speaker

No.	YS-01 - Young Scientists Award Session
Time:	09.45-10.30
Room:	Room 242A
Topic:	Brain Function
Session title:	Brain Function
	Lukas Pezawas, Austria	Chair
	Andrew Dwork, USA	Co-Chair

001	Amygdala hyperactivity in social anxiety disorder induced by facial attractiveness
	Andreas Hahn, Austria	Speaker
002	Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity
	Daniel Lindqvist, Sweden	Speaker
003	Are atypical antipsychotics "fire extinguisher" in the brain? The effect of atypical antipsychotics on microglial activation induced by interferon-gamma in vitro
	Takahiro Kato, Japan	Speaker

No.	D-01 - Debate
Time:	11.00-12.30
Room:	Room 351
Topic:	Brain Function
Session title:	Are the new brain stimulation methods ready for clinical use in psychiatry?
	Bruno Millet, France	Chair

	Thomas Schlaepfer, Germany	Proponent
	Mark George, USA	Opponent

No.	P-08 - Poster Presentation
Time:	12.30-14.00
Room:	Foyer
Topic:	Brain Function
Session title:	Brain Function I
	Gerhard Gründer, Germany	Chair

001	Pharmacological characterization of the rhesus macaque Nociceptin receptor
	Christophe Grundschober, Switzerland	Presenter
002	Possible role of FK-506 against 3-nitropropionic acid induced behavioral, biochemical, mitochondrial and neurochemical changes in striatum, cortex and hippocampus of rat brain
	Puneet Kumar Bansal, India	Presenter
003	The role of nitric oxide system in the anticonvulsant effect of the cannabinoid CB1 agonist ACEA in the pentylenetetrazole-induced seizure in mice
	Arash Bahremand, Iran	Presenter
005	[3H]-YM-09151-2 binding sites in human brain postmortem
	Donatella Marazziti, Italy	Presenter
006	A relationship between Brain-Derived Neurotrophic Factor and romantic attachment
	Donatella Marazziti, Italy	Presenter
007	Men axillary extracts modify the affinity of the platelet serotonin transporter and impulsiveness in women
	Donatella Marazziti, Italy	Presenter
008	Study of influence Agonists and Antagonists of Dopaminergic Receptors on morphine-induced analgesia and tolerance
	Elene Abzianidze, Georgia	Presenter
009	Uncoupling the D1-NMDA receptor complex Promotes NMDA-dependent LTP and working memory
	Fang Liu, Canada	Presenter
010	Phospholipids in dynamics of free radical oxidation of lipids in biological membranes brain under conditions of Parkinson’s disease
	Gayane Ghazaryan, Armenia	Presenter
011	Sarcosine reversed the MK-801-induced disruption of spontaneous alternation behavior in mice
	Shinji Takahashi, Japan	Presenter
012	Effect of sytemic administration of CH 113 on cognitive functions after excitotoxic hippocampus lesions in spatial learning task
	Lukas Rambousek, Czech Republic	Presenter
013	Limbic system surgery for the treatment of obsessive compulsive disorders
	Delcyr Antônio Costa, Brazil	Presenter
014	Involvement of 5-HT2B receptors in the regulation of energy homeostasis
	Sophie Banas, France	Presenter
015	First characterization of tryptophan hydroxylase 2 knockout mice
	Jonas Waider, Germany	Presenter
016	Possible Roles of BDNF - induced Microglial Intracellular Ca 2+ Elevation in the pathophysiology of psychiatric disorders
	Yoshito Mizoguchi, Japan	Presenter
017	Central effects of antidiuretic peptide desmopressin after its peripheral application on spontaneous behavior of rats
	Vera Klenerova, Czech Republic	Presenter
018	Renalase, a novel monoamine oxidase, is synthesised in the central nervous system
	Sarah Hennebry, Australia	Presenter
019	Is tyramine hydroxylation to dopamine operative in the brain?
	Anna Haduch, Poland	Presenter

No.	S-13 - Symposium
Time:	14.00-15.30
Room:	Blue Amphitheatre
Topic:	Brain Function
Track:	3 Interface
Session title:	Translational neuroscience: Do we learn anything for psychiatric practice?
	Dieter F. Braus, Germany	Chair
	Gabriele Sachs, Austria	Co-Chair

001	Neuroimaging in psychiatry
	Dieter F. Braus, Germany	Speaker
002	Sensorimotor gating and the tale of the prediction of antipsychotic effects
	Boris Quednow, Switzerland	Speaker
003	Biomarkers of affective disorders
	Lukas Pezawas, Austria	Speaker
004	Neurobiology of psychotherapy
	Gabriele Sachs, Austria	Speaker

No.	S-20 - Symposium
Time:	16.00-17.30
Room:	Blue Amphitheatre
Topic:	Brain Function
Track:	3 Interface
Session title:	Deep brain stimulation in repetitive behaviors
	Luc Mallet, France	Chair
	Paul Cosyns, Belgium	Co-Chair

001	Ventral capsule/ventral striatum stimulation in obsessive-compulsive disorder
	Benjamin Greenberg, USA	Speaker
002	Anatomical correlates of deep brain stimulation efficacy in obsessive compulsive disorder
	Leos Gabriels, Belgium	Speaker
003	Deep brain stimulation of the nucleus accumbens for therapy-refractory obsessive-compulsive disorder
	Damiaan Denys, Netherlands	Speaker
004	Effect of stimulation of limbic relays in basal ganglia on tics and compulsions
	Marie-Laure Welter, France	Speaker

« previous day	Monday, 29. June 2009	next day »

No.	PL-02 - Plenary Lecture
Time:	09.45-10.30
Room:	Main Amphitheatre
Topic:	Brain Function
Session title:	Globalization, market and brain sciences
	Robertas Bunevicius, Lithuania	Chair

001	Globalization, markets and the brain sciences
	Peter Whybrow, USA	Speaker

No.	P-18 - Poster Presentation
Time:	12.30-14.00
Room:	Foyer
Topic:	Brain Function
Session title:	Brain Function II
	Pierre Baumann, Switzerland	Chair

001	Analysis of a novel, stress-inducible transcript in the mouse brain
	Claudia Liebl, Germany	Presenter
002	Two types of personality changes due to brain damage: A case-control study
	Samvel Margaryan, Armenia	Presenter
004	Oxidative and antioxidative capacity in LPS treated mice
	Hans-Willi Clement, Germany	Presenter
005	To the role of hydrogensulfide in psychiatric disorders: A preliminary study in mice
	Hans-Willi Clement, Germany	Presenter
006	Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the acquisition and extinction of inhibitory avoidance
	Irit Akirav, Israel	Presenter
008	Neurotoxic trace elements in bipolar disorder
	Kazuhiro Tajima Pozo, Spain	Presenter
009	Matrix Metalloproteinases in the Cerebrospinal fluid of suicide attempters
	Shorena Janelidze, Sweden	Presenter
010	The role of Urocortin peptides in regulating the central stress response: Evidence from a novel Urocortin triple knockout mouse model
	Michael Tsoory, Israel	Presenter
011	GABAergic neurons in the lateral habenula regulate anxiety-related behabior via the serotonergic raphe neurons
	Konno Kohtarou, Japan	Presenter
012	Abnormal cortical morphology in offenders with psychopathy
	Marina Boccardi, Italy	Presenter
013	Abnormal hippocampal shape in offenders with psychopathy
	Marina Boccardi, Italy	Presenter
014	Pattern of cerebral anomalies in older persons with schizophrenia and Alzheimer’s disease
	Marina Boccardi, Italy	Presenter
015	Structural brain pathology and violent crime: Revisiting a possibly underestimated factor
	Kolja Schiltz, Germany	Presenter
016	Mediation of anticonvulsant effect of Locus Coeruleus via noradrenergic and galaninergic transmissions
	Nino Kuchiashvili, Georgia	Presenter
017	The reoencephalophy characteristic of the vascular channel at patients discirculatory Encephalopathy
	Sergey Radchenko, Ukraine	Presenter
018	Patterns of cognitive dysfunction in first psychosis episode and borderline personality disorder: A comparative neuropsychological study
	Kazuhiro Tajima Pozo, Spain	Presenter
019	Theta - burst repetitive transcranial magnetic stimulation of the motor cortex improves obsessive compulsive disorder: Preliminary findings of an open - label study
	Andrei Radtchenko, France	Presenter
020	Types of immune imbalance in patients with neurotic disorders
	Irina Kupriyanova, Russia	Presenter
021	A single session of temporo-parietal transcranial magnetic stimulation - may improve dyslexia
	Marco Antonio Marcolin, Brazil	Presenter

No.	FC-13 - Free Communications
Time:	14.00-15.30
Room:	Room 242A
Topic:	Brain Function
Session title:	Brain Function I
	Paul Cosyns, Belgium	Chair
	Nicole Praschak-Rieder, Austria	Co-Chair

001	Allelic variation in the serotonin transporter promoter modulates cortical excitability
	Goeran Hajak, Germany	Speaker
002	Lipopolysaccharide-induced free radical formation in the striatum of mice
	Hans-Willi Clement, Germany	Speaker
003	Optimise ECT techniques: The effects of pulse width manipulation on the amnesic side-effects of ECT treatment in depression
	Harm-Pieter Spaans, Netherlands	Speaker
004	Decreased BDNF serum levels in drug naïve non-depressed obsessive compulsive patients
	Luisella Bocchio-Chiavetto, Italy	Speaker
005	Verbal fluency and BDNF Val66Met polymorphism in schizophrenia
	Oussama Kebir, France	Speaker

No.	S-41 - Symposium
Time:	16.00-17.30
Room:	Room 241
Topic:	Brain Function
Track:	1 Basic
Session title:	Metabolism of psychotropic drugs in the human brain: Possible relevance for their clinical profile?
	Pierre Baumann, Switzerland	Chair
	Viji Ravindranath, India	Co-Chair

001	Brain-specific expression of cytochrome P450 enzymes and their impact on metabolism of psychoactive drugs at the site of action
	Viji Ravindranath, India	Speaker
002	Brain Cyp 4Fs in brain injury and psychotropic drug metabolism
	Henry Strobel, USA	Speaker
003	Monoamine oxidase: A challenging enzyme and its drugs
	Peter Riederer, Germany	Speaker
004	Selective metabolism of psychotropic drugs by MAO-A and MAO-B in brain
	Pierre Baumann, Switzerland	Speaker

« previous day	Tuesday, 30. June 2009	next day »

No.	S-43 - Symposium
Time:	08.00-09.30
Room:	Blue Amphitheatre
Topic:	Brain Function
Track:	3 Interface
Session title:	Immune activation and tryptophan metabolism in major psychiatric disorders
	Markus J. Schwarz, Germany	Chair
	Gilles Guillemin, Australia	Co-Chair

001	Tryptophan metabolism by astrocytes and microglia in neurodegenerative diseases
	Gilles Guillemin, Australia	Speaker
002	The outcome of postmortem studies of schizophrenia and bipolar disorder: Genes of relevance to tryptophan metabolism
	Christine L. Miller, USA	Speaker
003	Immune and tryptophan catabolic markers in blood and cerebrospinal fluid of patients with major depression and schizophrenia
	Aye-Mu Myint, Germany	Speaker
004	Immunomodulating therapy in major depression and schizophrenia
	Norbert Müller, Germany	Speaker

No.	SL-02 - Special Lecture
Time:	11.00-12.00
Room:	Blue Amphitheatre
Topic:	Brain Function
Session title:	From tragedy to tears: A neurobiological perpective
	René Kahn, Netherlands	Chair

001	From tragedy to tears: A neurobiological perspective
	Michael Trimble, United Kingdom	Speaker

No.	S-49 - Symposium
Time:	11.00-12.30
Room:	Salle Maillot
Topic:	Brain Function
Track:	2 Clinical
Session title:	Translational medicine in psychiatry; making sense of preclinical and clinical research: Methodologies, opportunities, and controversies
	Husseini Manji, USA	Chair
	Andrea De Bartolomeis, Italy	Co-Chair

001	Translational medicine of bipolar disorders
	Husseini Manji, USA	Speaker
002	Genetically determined dopamine signaling in schizophrenia phenotypes
	Alessandro Bertolino, Italy	Speaker
003	Major depressive disorder is a risk factor for osteoporosis in women
	Cizza Giovanni, USA	Speaker
004	Traslational studies and the search for new targets in psychosis treatment, methodology, success and failure
	Andrea De Bartolomeis, Italy	Speaker

No.	P-26 - Poster Presentation
Time:	12.30-14.00
Room:	Foyer
Topic:	Brain Function
Session title:	Brain Function III
	Matthaeus Willeit, Austria	Chair

001	Emotional processing within the Subthalamic nucleus in human
	Marie-Laure Welter, France	Presenter
002	A novelty / familiarity signal in the human dorsal thalamus
	Björn Schott, Germany	Presenter
003	No differences in the prevalence of cavum septum pellucidum and adhesio interthalamica between first-episode psychotic patients and healthy controls: A population-based study
	Clarissa Trzesniak, Brazil	Presenter
004	Reduced left hippocampal N-Acetylaspartate (NAA) in panic disorder patients detected by (1)H magnetic resonance spectroscopy imaging
	Clarissa Trzesniak, Brazil	Presenter
007	Basal hypothalamic pituitary adrenal axis activity and hippocampal volumes: The SMART-MR study
	Lotte Gerritsen, Netherlands	Presenter
008	Early and late life events and salivary cortisol in older persons
	Lotte Gerritsen, Netherlands	Presenter
009	Spatial memory following neurotoxin lesion of the basal cholinergic system
	Manana Dashniani, Georgia	Presenter
010	Correlation and predictor characteristics of the interhemispheric balance and Romberg's coefficient after electroconvulsive therapy
	Manol Gospodinov, Bulgaria	Presenter
011	Potentiation of Gamma Oscillatory Activity through Repetitive Transcranial Magnetic Stimulation (rTMS) of the Dorsolateral Prefrontal Cortex in Healthy Subjects
	Mera S. Barr, Canada	Presenter
012	Manic episode associated with temporal lobe epilepsy and sclerosis of amygdala and left hippocampal: A case report
	Mohamedi Darghal, Morocco	Presenter
013	Ultrastructural alterations of astrocytes in the hippocampus in schizophrenia
	Natalia Kolomeets, Russia	Presenter
014	The role of electroencephalography in diagnostic process in psychiatry - case report
	Nensi Manuseva, Macedonia, The former Yugoslav	Presenter
015	Metabolic syndrome in brain injury patients in a rehabilitation hospital
	Pardeep Singh Kundi, United Kingdom	Presenter
016	Peripheral nerve injury alters dopamine receptor numbers in the nucleus accumbens in a subpopulation of rats, which display sensory and affective disabilities
	Paul Austin, Australia	Presenter
017	Integrative function of single neurons in the human subthalamic nucleus during checking behavior
	Pierre Burbaud, France	Presenter
018	Age-related increase of the number of oligodendrocytes is dysregulated in the prefrontal cortex in schizophrenia and mood disorders
	Victor Vostrikov, Russia	Presenter
019	Involvement of the brain in the regulation of liver cytochrome P450 expression
	Wladyslawa Daniel, Poland	Presenter
021	Effects of pre-sleep negative mood induction on subsequent sleep
	Marie Vandekerckhove, Belgium	Presenter

No.	FC-22 - Free Communications
Time:	14.00-15.30
Room:	Room 242B
Topic:	Brain Function
Session title:	Brain Function II
	Klaus Ebmeier, United Kingdom	Chair
	Georg Juckel, Germany	Co-Chair

001	Mental fatigue and impaired information processing after brain injury
	Lars Rönnbäck, Sweden	Speaker
002	A meta-analysis comparing the placebo response of a non-pharmacological vs. a pharmacological intervention in major depressive disorder
	Andre Brunoni, Brazil	Speaker
003	Impaired cognition, sensorimotor gating, and hippocampal long-term depression in mice lacking the prostaglandin E2 EP2 receptor
	Tatiana Melnikova, USA	Speaker
004	Increased vulnerability of the mesencephalic dopaminergic systems of the human neonate to perinatal hypoxia: Implications in psychiatry
	Maria Panayotacopoulou, Greece	Speaker
005	Autonomic nervous system and its association with brain function in major depressive disorder
	Tye Dawood, Australia	Speaker
006	Striatum abnormalities in schizophrenia patients` families
	Vera Orlova, Russia	Speaker

No.	S-59 - Symposium
Time:	16.00-17.30
Room:	Room 251
Topic:	Brain Function
Track:	3 Interface
Session title:	New strategies and tools in the field of transcranial magnetic stimulation (TMS)
	Yechiel Levkovitz, Israel	Chair
	Frank Padberg, Germany	Co-Chair

001	Deep transcranial magnetic stimulation in major depression: Feasibility and safety study
	Yechiel Levkovitz, Israel	Speaker
002	New protocols of non-invasive brain stimulation: Enhancing the after-effect
	Frank Padberg, Germany	Speaker
003	Gamma synchrony, GABAB and rTMS cognitive enhancing strategies in schizophrenia
	Z. Jeff Daskalakis, Canada	Speaker
004	Physiological optimization of TMS pulse shape and parameters for therapeutic applications: Controllable pulse shape TMS (cTMS) and magnetic seizure therapy (MST)
	Sarah H. Lisanby, USA	Speaker

« previous day	Wednesday, 1. July 2009	next day »

No.	S-70 - Symposium
Time:	11.00-12.30
Room:	Room 241
Topic:	Brain Function
Track:	1 Basic
Session title:	Glia cell pathology in psychiatric disorders
	Matthias Rothermundt, Germany	Chair
	Damir Janigro, USA	Co-Chair

001	Glial changes in post mortem brains of individuals with psychiatric disorders
	Johann Steiner, Germany	Speaker
002	Astroglial antioxidant defense alteration in bipolar disorder
	Carlos Alberto Goncalves, Brazil	Speaker
003	Inflammatory markers in children and adolescents with psychotic disorders, the role of glia cells
	Tatiana Falcone, USA	Speaker
004	Glial activation in psychiatric disorders
	Matthias Rothermundt, Germany	Speaker

No.	TG-08 - WFSBP Treatment Guidelines
Time:	16.00-17.30
Room:	Room 242A
Topic:	Brain Function
Session title:	Biological markers
	Olya Mikova, Bulgaria	Chair

	Toshikazu Saito, Japan	Presenter
	Peter Riederer, Germany	Presenter

No.	SL-03 - Special Lecture
Time:	16.30-17.30
Room:	Blue Amphitheatre
Topic:	Brain Function
Session title:	Brain, mind, society: The threefold cord
	Joseph Zohar, Israel	Chair

001	Brain, mind, society: the threefold cord
	Alain Ehrenberg, France	Speaker

« previous day	Thursday, 2. July 2009

No.	S-76 - Symposium
Time:	08.00-09.30
Room:	Blue Amphitheatre
Topic:	Brain Function
Track:	1 Basic
Session title:	Neuroanatomical aspects of prepulse inhibition in schizophrenia: Animal models and human psychoses
	Rainer Wolf, Germany	Chair
	Georg Juckel, Germany	Co-Chair

001	Reduction of prepulse inhibition (PPI) after neonatal excitotoxic lesion of the ventral thalamus in pubertal and adult rats
	Rainer Wolf, Germany	Speaker
002	Perinatal hypoxia as probable animal model of schizophrenia
	Andrea Schmitt, Germany	Speaker
003	Pharmacological studies of prepulse inhibition models of schizophrenia
	Maarten van den Buuse, Australia	Speaker
004	Brain imaging (fMRI) studies of startle gating deficits in schizophrenia patients treated with typical or atypical antipsychotics
	Veena Kumari, United Kingdom	Speaker

No.	S-81 - Symposium
Time:	11.00-12.30
Room:	Salle Maillot
Topic:	Brain Function
Track:	1 Basic
Session title:	Social cognition, social hormones and psychophathology
	Richard Ebstein, Israel	Chair
	Andreas Meyer-Lindenberg, Germany	Co-Chair

001	Neural and genetic mechanisms of human social behavior
	Andreas Meyer-Lindenberg, Germany	Speaker
002	Neuroanatomical bases of envy and gloating (schadenfreude)
	Simone Shamay-Tsoory, Israel	Speaker
003	The neuroendocrinology of social cognition
	Markus Heinrichs, Switzerland	Speaker
004	Genetics of social cognition
	Salomon Israel, Israel	Speaker

No.	FC-36 - Free Communications
Time:	12.30-14.00
Room:	Room 242B
Topic:	Brain Function
Session title:	Brain Function III
	Frank Padberg, Germany	Chair
	Prakash S. Masand, USA	Co-Chair

001	Sub-thalamic deep brain stimulation decreases metabolic activity in pre-frontal cortex in patients suffering from obsessive compulsive disorder
	Bruno Millet, France	Speaker
002	Effects of isolation-rearing on hippocampal cytoskeletal microtubular proteins, synaptic markers and behavioural phenotype in Sprague Dawley and Flinders Sensitive Line rats
	Massimiliano Bianchi, France	Speaker
003	Psychiatric disorder biomarker discovery - from differential expression to isoforms to pathways
	Chris Turck, Germany	Speaker
004	Determination of T-Cell subpopulations in CSF and peripheral blood in patients with affective and schizophrenic spectrum disorders to assess immunosurveillance and to apply as a diagnostic approach
	Karl Bechter, Germany	Speaker
005	A cytokine model of cognitive function
	Bernhard Baune, Australia	Speaker
006	Repetitive Transcranial Magnetic Stimulation (rTMS) in treatment of resistant obsessive-compulsive disorder
	Carlos Mansur, Brazil	Speaker

No.	P-47 - Poster Presentation
Time:	12.30-14.00
Room:	Foyer
Topic:	Brain Function
Session title:	Brain Function IV
	Michael Trimble, United Kingdom	Chair

001	Efficiency and security with TMS in depressive episodes
	Beatriz Quadrelli, Uruguay	Presenter
002	Change in heart rate variability after electroconvulsive therapy in patients with major depressive disorders
	Ali Bozkurt, Turkey	Presenter
003	Reduced cortical inhibition in Japanese patients with schizophrenia under medication
	Asami Kose, Japan	Presenter
004	Repetitive transcranial magnetic stimulation: Elderly depressed-neuronavegated study
	Bianca Bellini, Brazil	Presenter
005	The influence of HF-rTMS treatment on 5-HT 2A receptor binding in medication-resistant unipolar depressed patients
	Chris Baeken, Belgium	Presenter
006	Monitoring of ECT Service in a Mental Health Trust in the UK: An audit-based report
	Guru Rao Srinivasan, United Kingdom	Presenter
007	Optimise ECT techniques: The effects of pulse width manipulation on the efficacy of ECT treatment in depression
	Harm-Pieter Spaans, Netherlands	Presenter
008	ECT efficacy: Correlations between clinical improvement, memory performance and memory complaints
	Daniel Barrocas, Portugal	Presenter
009	Influence of right frontal repetitive Transcranial Magnetic Stimulation (rTMS) on the affective picture perception
	Jacqueline Hoeppner, Germany	Presenter
010	Changes in brain activities evoked by masked traumatic stimuli in patients with Posttraumatic Stress Disorder (PTSD): A functional MRI study
	Jeong-Ho Chae, Korea, Republic of	Presenter
011	The effect of repetitive transcranial magnetic stimulation (rTMS) on fear extinction in rats
	Jeong-Ho Chae, Korea, Republic of	Presenter
012	From psychopathology to psychosurgery - leaving the localisationist rationale behind?
	Lara Rzesnitzek, Germany	Presenter
013	Instantaneous and complete suppression of motor tics and obsession and compulsions with unilateral thalamic deep brain stimulation in Tourette - Syndrome
	Lara Rzesnitzek, Germany	Presenter
014	Repetitive transcranial magnetic stimulation postpartum depression treatment neurocognitive and behavioral symptomatology therapeutic effects
	Martin Myczkowski, Brazil	Presenter
015	Predictors of response to electroconvulsive therapy obtained using the three - factor structures of the Montgomery and Åsberg Depression Rating Scale for major depressive disorders in Japanese patients
	Mioto Okazaki, Japan	Presenter
016	Abnormalities in cortical and trans-callosal inhibitory mechanisms in subjects at high-risk for alcohol dependence: A TMS study
	Muralidharan Kesavan, India	Presenter
017	Effect of augmentative repetitive transcranial magnetic stimulation in resistant obsessive - compulsive disorder: A preliminary study
	Sunil Mittal, India	Presenter
018	Transcranial direct current stimulation (tDCS) in therapy - resistant depression: A double-blind, placebo - controlled study
	Ulrich Palm, Germany	Presenter
019	The use of transcranial laser stimulation for treating developmental language deficits in the preschool period
	Victor Sevastyanov, Russia	Presenter

No.	W-14 - Workshop
Time:	14.00-15.30
Room:	Room 242B
Topic:	Brain Function
Session title:	Prefrontal cortex-relevance in psychiatry
	E. Mohandas, India	Chair

001	Prefrontal cortex - functional neuroanatomy
	E. Mohandas, India	Speaker
002	Prefrontal cortex - relevance to psychiatric disorders
	Venkat Subramaniam, India	Speaker

No.	S-86 - Symposium
Time:	14.00-15.30
Room:	Blue Amphitheatre
Topic:	Brain Function
Track:	1 Basic
Session title:	Neural circuitry and mood disorders: Relationship to course of illness and treatment outcome
	Russell Joffe, USA	Chair
	Thomas Frodl, Germany	Co-Chair

001	Neural circuitry in depression: Concepts and rationale
	Russell Joffe, USA	Speaker
002	Hippocampal volumes predict remission rates early in the course of depression
	Glenda MacQueen, Canada	Speaker
003	Has depression-related decline of brain morphology an impact on illness course?
	Thomas Frodl, Germany	Speaker
004	Towards the development of neurobiological predictors of treatment response: Studies in neuroimaging
	Cynthia Fu, United Kingdom	Speaker

« Back

---